1. 1. Levey AS, Eckardt K-U, Tsukamoto Y, et al. Definition and classification chronic kidney disease: A position statement from kidney disease: Improving Global Outcomes (KDIGO). Kidney Int 67: 2089-2100, 2005.
2. 2. Masakane I, Nakai S, Ogata S, et al. An overview of regular dialysis treatment in Japan (as of December 31, 2014). J Jpn Soc Dial Ther 49: 1-34, 2016 (in Japanese).
3. 3. Lazarus JM, Lowrie G, Hampaers CL, Merrill JP. Cardiovascular disease in uremic patients on hemodialysis. Kidney Int 7 (Suppl): 167-175, 1975.
4. 4. Okada M, Imamura K, Iida M, Omae T. Hypophosphatemia induced by intravenous administration of saccharated iron oxide. Klin Wochenshr 61: 99-102, 1983.
5. 5. Imamura K. Effects intravenous administration of iron preparation on the metabolism of phosphorus. Fukuoka Acta Med 75: 316-326, 1984.